Cochrane Abstracts
Levomepromazine for schizophrenia
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Levomepromazine for Schizophrenia." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/437733/all/Levomepromazine_for_schizophrenia.
Levomepromazine for schizophrenia. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/437733/all/Levomepromazine_for_schizophrenia. Accessed January 15, 2025.
Levomepromazine for schizophrenia. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/437733/all/Levomepromazine_for_schizophrenia
Levomepromazine for Schizophrenia [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 January 15]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/437733/all/Levomepromazine_for_schizophrenia.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Levomepromazine for schizophrenia
ID - 437733
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/437733/all/Levomepromazine_for_schizophrenia
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
